The cyclophilin inhibitor CRV431 prevents both cyclophilin A-HBx complex formation and HBV replication

Detalles Bibliográficos
Autores principales: Foster, R.T., Ure, D.R., Trepanier, D.J., Gallay, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Association for the Study of the Liver. Published by Elsevier B.V. 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172068/
http://dx.doi.org/10.1016/S0168-8278(17)31875-5
_version_ 1783524182822223872
author Foster, R.T.
Ure, D.R.
Trepanier, D.J.
Gallay, P.
author_facet Foster, R.T.
Ure, D.R.
Trepanier, D.J.
Gallay, P.
author_sort Foster, R.T.
collection PubMed
description
format Online
Article
Text
id pubmed-7172068
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher European Association for the Study of the Liver. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-71720682020-04-22 The cyclophilin inhibitor CRV431 prevents both cyclophilin A-HBx complex formation and HBV replication Foster, R.T. Ure, D.R. Trepanier, D.J. Gallay, P. J Hepatol Article European Association for the Study of the Liver. Published by Elsevier B.V. 2017 2017-05-11 /pmc/articles/PMC7172068/ http://dx.doi.org/10.1016/S0168-8278(17)31875-5 Text en Copyright © 2017 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Foster, R.T.
Ure, D.R.
Trepanier, D.J.
Gallay, P.
The cyclophilin inhibitor CRV431 prevents both cyclophilin A-HBx complex formation and HBV replication
title The cyclophilin inhibitor CRV431 prevents both cyclophilin A-HBx complex formation and HBV replication
title_full The cyclophilin inhibitor CRV431 prevents both cyclophilin A-HBx complex formation and HBV replication
title_fullStr The cyclophilin inhibitor CRV431 prevents both cyclophilin A-HBx complex formation and HBV replication
title_full_unstemmed The cyclophilin inhibitor CRV431 prevents both cyclophilin A-HBx complex formation and HBV replication
title_short The cyclophilin inhibitor CRV431 prevents both cyclophilin A-HBx complex formation and HBV replication
title_sort cyclophilin inhibitor crv431 prevents both cyclophilin a-hbx complex formation and hbv replication
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172068/
http://dx.doi.org/10.1016/S0168-8278(17)31875-5
work_keys_str_mv AT fosterrt thecyclophilininhibitorcrv431preventsbothcyclophilinahbxcomplexformationandhbvreplication
AT uredr thecyclophilininhibitorcrv431preventsbothcyclophilinahbxcomplexformationandhbvreplication
AT trepanierdj thecyclophilininhibitorcrv431preventsbothcyclophilinahbxcomplexformationandhbvreplication
AT gallayp thecyclophilininhibitorcrv431preventsbothcyclophilinahbxcomplexformationandhbvreplication
AT fosterrt cyclophilininhibitorcrv431preventsbothcyclophilinahbxcomplexformationandhbvreplication
AT uredr cyclophilininhibitorcrv431preventsbothcyclophilinahbxcomplexformationandhbvreplication
AT trepanierdj cyclophilininhibitorcrv431preventsbothcyclophilinahbxcomplexformationandhbvreplication
AT gallayp cyclophilininhibitorcrv431preventsbothcyclophilinahbxcomplexformationandhbvreplication

Ejemplares similares